Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
Tax Provision
Mereo Biopharma Group PLC
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
Tax Provision
£1.9m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Tax Provision
$25.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Tax Provision
$19k
|
CAGR 3-Years
-91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Tax Provision
-$1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-85%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Tax Provision
£5.6m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Tax Provision
-£8.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
See Also
What is Mereo Biopharma Group PLC's Tax Provision?
Tax Provision
1.9m
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Tax Provision amounts to 1.9m GBP.
What is Mereo Biopharma Group PLC's Tax Provision growth rate?
Tax Provision CAGR 3Y
-33%
The average annual Tax Provision growth rates for Mereo Biopharma Group PLC have been -33% over the past three years .